Related Experiment Video
Updated: Mar 7, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Gonococcal outer membrane vesicle vaccines: bacterial population biology, clinical trials, immune profiling, and
Zhenyi Gu1, Anastasia Unitt2, Odile B Harrison2
1Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Abstract:
Gonorrhoea is a global health concern exacerbated by rising antimicrobial resistance. Retrospective analyses indicate that outer membrane vesicle (OMV) vaccines derived from Neisseria meningitidis (MeNZB, 4CMenB) may offer partial cross-protection against gonococcal infection. This review outlines the influence of gonococcal population biology on coverage, immune responses elicited by 4CMenB, and emerging strategies that offer the prospect of rationally designed vaccines dedicated to the prevention of gonococcal disease.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Vaccinations

